Mesa Laboratories, Inc. (NasdaqGS:MLAB) acquired Sterilization indicators business of GKE-GmbH and SAL GmbH from Gke-GmbH for ?80 million on October 14, 2023. The consideration will be paid in cash and will be funded with proceeds from credit facility and cash on hand. In a related transaction Mesa Laboratories, Inc. (NasdaqGS:MLAB) will acquire Beijing GKE Science & Technology Co. LTD for ?5 million.

Mesa Laboratories, Inc. (NasdaqGS:MLAB) completed the acquisition of Sterilization indicators business of GKE-GmbH and SAL GmbH from Gke-GmbH on October 14, 2023. Of the total acquisition price of ?80 million, net of cash and debt, ?8.5 million will be held back for a period of 18 months from the acquisition closing date as security against potential indemnification losses. The acquisition was funded through a combination of cash on-hand and ?61.3809 million borrowed under our line of credit.